Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease.

RPEP-077022024Al-Sabah, Salman; Al-Khairi, Irina; Jamal, Mohammad; Qaddoumi, Mohammad; Alajmi, Fahad; Kumar, Jijin; Abukhalaf, Nermeen; Cherian, Preethi; Madhu, Dhanya; Arefanian, Hossein; Dsouza, Carol; Alam-Eldin, Nada; AlSabagh, Abdullah; Al Madhoun, Ashraf; Al-Sabah, Suleiman; Al-Mulla, Fahd; Abu-Farha, Mohamed; Abubaker, Jehad

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 33(5), 478-490

View on PubMed ↗Publisher’s paper ↗

Citation

Al-Sabah, Salman; Al-Khairi, Irina; Jamal, Mohammad; Qaddoumi, Mohammad; Alajmi, Fahad; Kumar, Jijin; Abukhalaf, Nermeen; Cherian, Preethi; Madhu, Dhanya; Arefanian, Hossein; Dsouza, Carol; Alam-Eldin, Nada; AlSabagh, Abdullah; Al Madhoun, Ashraf; Al-Sabah, Suleiman; Al-Mulla, Fahd; Abu-Farha, Mohamed; Abubaker, Jehad. (2024). Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease.. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 33(5), 478-490. https://doi.org/10.1159/000540534